WCLC 2018: Importance of QOL outcome measures in clinical trials

WCLC co-Presidents Professor Andrea Bezjak and Dr Natasha Leighl (both of Toronto, Canada) discuss research from their centre on the iimportance of QOL outcome measures in clinical trials.

Interviewer Esther Drain